What We're Reading: Page 10
Industry reads hand-picked by our editors
Sep 16, 2025
Sep 12, 2025
-
Axios
Trump will force drugmakers to lower prices, Lutnick says
-
KFF Health News
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
-
New England Journal of Medicine
Transformative Research in Cystic Fibrosis
-
Derek Thomspon
The Age of Diagnosis: How the Over-Medicalization Of Everything Makes Us Sick, Anxious, and Lost
Sep 11, 2025
-
Associated Press
Trump’s plan for a drug advertising crackdown faces many hurdles
-
The Wall Street Journal
Health Officials Hunt for Cases Connecting Covid Shot and Harm in Pregnant Women
-
Reuters
Private equity firm Advent to sell drugmaker Zentiva to GTCR
Sep 10, 2025
-
The New York Times
Trump Weighs Crackdown on Medicines From China
-
Bloomberg
Fired CDC Director to Testify in Senate on Turmoil at the Agency
-
404 Media
HHS Asks All Employees to Start Using ChatGPT
Sep 09, 2025
Sep 08, 2025
-
Axios
China pharma deals threaten U.S. biotech
-
The New York Times
David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87
-
The Wall Street Journal
The Billionaires Fueling the Quest for Longer Life
-
NPR
This is what could happen to a child who doesn’t get vaccinated
Sep 05, 2025
-
Bloomberg
BioZorb Breast Cancer Device Injuries Were Kept Secret for Years
-
FirstWord Pharma
Study success for DualityBio’s ADC boosts BioNTech’s oncology ambitions
-
BioCentury
Rep. Auchincloss challenges FDA’s new priority voucher program
-
Stat
Donavon Decker knew a gene therapy experiment wouldn’t help him. To help others, he still said yes
Previous
